Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Total Liabilities: 2015-2020

Historic Total Liabilities for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $19.3 million.

  • Outlook Therapeutics' Total Liabilities fell 44.24% to $19.3 million in Q2 2020 from the same period last year, while for Jun 2020 it was $19.3 million, marking a year-over-year decrease of 44.24%. This contributed to the annual value of $27.9 million for FY2019, which is 35.25% down from last year.
  • Outlook Therapeutics' Total Liabilities amounted to $19.3 million in Q2 2020, which was down 42.79% from $33.7 million recorded in Q1 2020.
  • In the past 5 years, Outlook Therapeutics' Total Liabilities ranged from a high of $51.5 million in Q3 2017 and a low of $19.3 million during Q2 2020.
  • Moreover, its 3-year median value for Total Liabilities was $38.0 million (2018), whereas its average is $36.1 million.
  • Per our database at Business Quant, Outlook Therapeutics' Total Liabilities crashed by 51.12% in 2016 and then surged by 68.29% in 2017.
  • Quarterly analysis of 5 years shows Outlook Therapeutics' Total Liabilities stood at $42.3 million in 2016, then declined by 4.98% to $40.2 million in 2017, then increased by 0.01% to $40.2 million in 2018, then decreased by 10.82% to $35.8 million in 2019, then crashed by 44.24% to $19.3 million in 2020.
  • Its last three reported values are $19.3 million in Q2 2020, $33.7 million for Q1 2020, and $35.8 million during Q4 2019.